a 5-tiered CT scoring algorithm may represent a clinically useful tool for diagnosis of clear-cell renal cell carcinoma (RCC) in small (≤4 cm) solid renal masses.

72-year-old man with right interpolar 3.2-cm renal mass. Axial CT images in the (A) unenhanced, (B) corticomedullary, and (C) nephrographic phases at the same level depict the mass (arrow, A and C), which shows avid heterogeneous enhancement. Circular ROIs were placed in the most enhancing component of the mass and in ipsilateral renal cortex (circles, B), to determine the mass-to-cortex corticomedullary attenuation ratio. Heterogeneity scores were assigned subjectively using a 5-point Likert type-scale. These two features were used to inform development of the CT score. In this patient, the mass showed avid enhancement (mass-to-cortex corticomedullary enhancement ratio >0.75) and was considered completely heterogeneous (heterogeneous score, 5) by both radiologists, resulting in CT score 5. Nephrectomy revealed clear-cell renal cell carcinoma. 


June 30, 2022 — According to ARRS’ American Journal of Roentgenology (AJR), a 5-tiered CT scoring algorithm may represent a clinically useful tool for diagnosis of clear-cell renal cell carcinoma (RCC) in small (≤4 cm) solid renal masses

“A 5-tiered renal CT algorithm, including mass-to-cortex corticomedullary attenuation ratio and heterogeneity score, had substantial inter-observer agreement, moderate AUC and PPV, and high NPV for diagnosing clear-cell RCC,” concluded Nicola Schieda from the department of medical imaging at Canada’s Ottawa Hospital. 

Schieda and colleagues’ study included 148 patients (mean age, 58 years; 73 men, 75 women) with 148 small (≤4 cm) solid (>25% enhancing tissue) renal masses that underwent renal-mass CT (unenhanced, corticomedullary, and nephrographic phases) before resection between January 2016 and December 2019. Two radiologists independently evaluated CT examinations and recorded calcification, mass attenuation in all phases, mass-to-cortex corticomedullary attenuation ratio, and heterogeneity score (5-point Likert scale, assessed in corticomedullary phase). 

Ultimately, Schieda et al’s 5-tiered CT scoring algorithm—including mass-to-cortex corticomedullary attenuation ratio and heterogeneity score—had substantial interobserver agreement (weighted kappa=0.71) and achieved AUC for diagnosing clear-cell RCC of 0.75 (95% CI, 0.68-0.82) for reader 1 and 0.72 (95% CI, 0.66-0.82) for reader 2. 

“If validated,” the authors of this AJR article acknowledged, “the CT algorithm may represent a useful clinical tool for diagnosing clear-cell renal cell carcinoma.” 

For more information: www.arrs.org 


Related Content

News | Artificial Intelligence

March 17, 2023 — A new paper published in the Journal of Medical Internet Research describes how generative models such ...

Time March 17, 2023
arrow
News | Lung Imaging

March 15, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR) ...

Time March 15, 2023
arrow
News | Coronavirus (COVID-19)

March 13, 2023 — According to an accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR) ...

Time March 13, 2023
arrow
News | Artificial Intelligence

March 10, 2023 — Computed tomography (CT) is one of the most powerful and well-established diagnostic tools available to ...

Time March 10, 2023
arrow
News | Contrast Media

March 2, 2023 — GE HealthCare announced at the European Congress of Radiology (ECR) in Vienna, Austria, the completion ...

Time March 02, 2023
arrow
News | SPECT-CT

March 2, 2023 —Royal Philips announced new milestones in the development of the world’s first spectral detector angio CT ...

Time March 02, 2023
arrow
News | X-Ray

March 2, 2023 — Carestream Health is funding and participating in an innovative pilot with the Open Source Imaging ...

Time March 02, 2023
arrow
News | Computed Tomography (CT)

March 1, 2023 — According to an accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR), using a ...

Time March 01, 2023
arrow
News | Artificial Intelligence

February 24, 2023 — Qure.ai, a leading provider of artificial intelligence (AI) software for medical imaging, announced ...

Time February 24, 2023
arrow
News | Computed Tomography (CT)

February 22, 2023 — According to an accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR) ...

Time February 22, 2023
arrow
Subscribe Now